-
REAL-WORLD ECONOMIC OUTCOMES ASSOCIATED WITH SWITCHING BETWEEN BIOLOGICS AND BIOSIMILARS IN IMMUNE-MEDIATED INFLAMMATORY DISEASES
Mar 18, 2026, 21:38 PM -
COST-UTILITY OF PNEUMOCOCCAL VACCINATION STRATEGIES FOR ADULTS AGED 50 AND OLDER IN COLOMBIA: A MODEL-BASED ECONOMIC EVALUATION
Mar 18, 2026, 21:38 PM -
TRENDS IN UTILIZATION AND OUT-OF-POCKET SPENDING FOR GLP-1 RECEPTOR AGONISTS AMONG U.S. ADULTS WITH TYPE 2 DIABETES, 2018-2023: A MEPS STUDY
Mar 18, 2026, 21:38 PM -
ALIGNMENT OF ESTIMATED ACQUISITION COSTS IN U.S. GENE THERAPY COST EFFECTIVENESS ANALYSES WITH STANDARD PRICE BENCHMARKS
Mar 18, 2026, 21:38 PM -
VALIDATION OF A CLAIMS ALGORITHM TO IDENTIFY PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1 (DM1)
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF ¹77LU-PSMA-617 VERSUS CABAZITAXEL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: AN ANALYSIS BASED ON REAL-WORLD DATA AND THERAP TRIAL
Mar 18, 2026, 21:38 PM -
BARRIERS TO RECOVERY AND THE ASSOCIATION BETWEEN SHARED DECISION-MAKING AND RETENTION IN CARE AMONG PERINATAL WOMEN WITH OPIOID USE DISORDER
Mar 18, 2026, 21:38 PM -
SHAREHOLDERS AND COMMON OWNERSHIP IN THE MARKET FOR MONOCLONAL ANTIBODIES: A NETWORK ANALYSIS
Mar 18, 2026, 21:38 PM -
A NOVEL MULTIVARIATE APPLICATION OF PROFILE ANALYSIS TO CHARACTERIZE MULTIDOMAIN PATIENT-REPORTED OUTCOME (PRO) PATTERNS IN PATIENTS WITH GASTRIC OR GASTROESOPHAGEAL JUNCTION (GC/GEJC) ADENOCARCINOMA
Mar 18, 2026, 21:38 PM -
EVALUATING MARGINAL HEALTHCARE EXPENDITURESACROSS DEMOGRAPHIC SUBGROUPS IN DEMENTIA USING BAYESIAN HIERARCHICAL MODELS
Mar 18, 2026, 21:38 PM -
PATIENT-REPORTED OUTCOMES IN UNITED STATES PROMOTIONAL COMMUNICATIONS FOR DRUGS AND BIOLOGICS: A REVIEW OF DRUG PROMOTION UNTITLED LETTERS FROM THE FDA
Mar 18, 2026, 21:38 PM -
THE ANALYTICAL FRAMEWORK OF CLINICAL TRIALS EVALUATING CLINICAL OUTCOMES OF ARTIFICIAL INTELLIGENCE-BASED DIGITAL HEALTH INTERVENTIONS FOR METABOLIC DISORDERS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
DOES VULNERABILITY DRIVE UTILIZATION: ASSESSING DIFFERENTIAL HEALTHCARE UTILIZATION AMONG DUAL-ELIGIBLE VERSUS FEE-FOR-SERVICE MEDICARE BENEFICIARIES FROM EARLY TO MID-STAGE AD/ADRD/MCI
Mar 18, 2026, 21:38 PM -
CLINICAL AND HEALTHCARE FACTORS ASSOCIATED WITH DIABETIC KETOACIDOSIS AT PEDIATRIC TYPE 1 DIABETES DIAGNOSIS IN THE US AND ENGLAND
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS ANALYSIS OF FOLFIRINOX AND GEMCITABINE PLUS NAB-PACLITAXEL IN METASTATIC PANCREATIC ADRENOCARCINOMA; USING MARGINAL STRUCTURAL MODEL
Mar 18, 2026, 21:38 PM -
REAL-WORLD PRESCRIPTION PATTERNS, ADHERENCE, AND LDL REDUCTION OF PCSK9 INHIBITOR USERS IN CHINA: EVIDENCE FOLLOWING NRDL INCLUSION
Mar 18, 2026, 21:38 PM -
A FRAMEWORK FOR INTEGRATING THE ESTIMANDS INTO FEASIBILITY OF NETWORK META-ANALYSES OF RANDOMIZED CONTROLLED TRIALS
Mar 18, 2026, 21:38 PM -
THE COST-EFFECTIVENESS AND GLOBAL REIMBURSEMENT LANDSCAPE FOR DENOSUMAB IN ONCOLOGY
Mar 18, 2026, 21:38 PM -
ACANTHOSIS NIGRICANS AS A CLINICAL MARKER FOR SCREENING OF POLYCYSTIC OVARY SYNDROME AMONG YOUNG WOMEN
Mar 18, 2026, 21:38 PM -
CAREGIVER IMPACT VALUE FRAMEWORK: UNLOCKING SOCIETAL VALUE
Mar 18, 2026, 21:38 PM
